[1] 杨新华,钟兰俊,李延特,等. 紫杉醇和顺铂加放疗同步治疗Ⅲ期非小细胞肺癌临床观察 [J].中国肿瘤临床与康复,2007,12(12):163-165.[2] 仇晓军,马剑波,季 斌,等.康莱特加同步放化疗治疗局部晚期非小细胞肺癌的临床研究 [J].临床肿瘤学杂志,2007,12(2):131-133.[3] Trotti A,Colevas AD,Setser A,et al.CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment [J].Semin Radiat Oncol,2003,13(3):176-181.[4] Rodrigues G,Lock M,D'Souza D,et al.Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review [J].Radiother Oncol,2004,71(2):127-138.[5] Willner J,Jost A, Baier K, et al.A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy [J].Strahlenther Onkol,2003,179(8):548-566.[6] Tang C,Gomez DR,Wang H,et al.Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer [J].Int J Radiat Oncol Biol Phys,2014,88(2):319-325.[7] Wang D, Zhu J,Sun J,et al.Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy [J].Clin Transl Oncol,2012,14(12):943-952.[8] Farr KP,Khalil AA,Knap MM,et al.Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients [J].Radiother Oncol,2013,107(3):382-388.[9] Liu Y, Xia T, Zhang W,et al.Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis [J]. Radiat Oncol,2013,8(1):189-197.[10] Piotrowski T,Matecka-Nowak M,Milecki P.Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy [J]. Neoplasma,2005,52(1):56-62.[11] Agrawal S,Kumar S,Lawrence A,et al.Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy [J].South Asian J Cancer,2014,3(1):13-15.[12] Appalanaido GK,Arul E,Choung WL.Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas [J].Radiat Oncol,2013,8(1):268-279.[13] Nomura M,Kodaira T,Furutani K,et al.Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation [J].Br J Radiol,2012,85(1014):813-818.[14] Kim B,Park HC,Oh D,et al.Development of the DVH management software for the biologically-guided evaluation of radiotherapy plan [J].Radiat Oncol J,2012,30(1):43-48.[15] Uno T,Isobe K,Kawakami H,et al.Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer [J].Int J Clin Oncol,2006,11(1):55-59.[16] Barriger RB,Forquer JA,Brabham JG,et al.A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy [J].Int J Radiat Oncol Biol Phys,2012,82(1):457-462.[17] 王 澜,高 超,韩 春,等.DVH参数对局部晚期非小细胞肺癌同期化放疗肺损伤的预测价值研究 [J].中华放射医学与防护杂志,2010,30(6):725-727.[18] 杨 阳,闫 婧,刘 娟,等.胸部放疗放射性肺炎病因学相关因素分析 [J].中华肿瘤防治杂志,2012,19(6): 446-449.[19] Wang D,Shi J,Liang S,et al.Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve [J].Clin Transl Oncol,2013,15(5):364-369.[20] Hoover DA,Reid RH,Wong E,et al.SPECT-based functional lung imaging for the prediction of radiation pneumonitis: a clinical and dosimetric correlation [J].J Med Imaging Radiat Oncol,2014,58(2):214-222. |